Table 1.

Baseline variables between target group (sarcoidosis patients) and control group.

Variables	Sarcoidosis (n = 46,289)	No sarcoidosis (n = 17,967,589)	P
Age [years]	58.2 ± 13.6	57.3 ± 20.6	< 0.001
Male	35.8% (16,556)	40.9% (7,352,675)	< 0.001
Diabetes mellitus	31.60% (14,626)	21.25% (3,818,578)	< 0.001
Hypertension	65.20% (30,179)	51.74% (9,297,154)	< 0.001
Chronic kidney disease	21.09% (9,763)	14.02% (2,519,784)	< 0.001
Acute coronary syndrome	3.35% (1,551)	4.32% (777,054)	< 0.001
Heart failure	24.87% (11,510)	15.01% (2,696,906)	< 0.001
Charlson-Deyo Index	2.3 ± 2.07	1.7 ± 2.15	< 0.001
Ventricular tachycardia	2.29% (1,059)	1.22% (218,330)	< 0.001
Ventricular fibrillation	0.25% (118)	0.21% (38,012)	< 0.001
Cardiac arrest	0.72% (331)	0.60% (108,312)	< 0.001